Ajax-Loading

Novartis AG - Cash Ratio

Novartis AG's Fiscal Year is From January To December.

The item "Cash-Ratio" stands at 0.3048 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Cash Ratio" stands at 0.3048. This represents an increase of 38.08 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -38.84 percent compared to the value the year prior.
The 1 year change in percent is -38.84.
The 3 year change in percent is -55.07.

The Serie's long term average value is 0.438. It's latest available value, on 09/30/2025, is 30.42 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +38.08%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -57.35%.

Cash Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash Ratio905,699,262,464.00
LogoJohnson & Johnson - Cash Ratio486,508,953,600.00
LogoAbbVie Inc - Cash Ratio399,570,305,024.00
LogoRoche Holding AG - Cash Ratio317,433,206,677.55
LogoAstraZeneca PLC - Cash Ratio280,205,508,085.11